Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are there effective remedies for lipitor induced stomach discomfort?Imipramine brand name?Eylea patents expired?Sunitinib malate market?Brand name for imipramine?
See the DrugPatentWatch profile for eltrombopag
Whether eltrombopag’s patents have expired “now” depends on which specific patent (and which country) you mean. Patent protection is granted patent-by-patent and expires at different times, so it’s common for some patents to expire earlier while others remain in force. DrugPatentWatch.com is a useful place to check the latest status by jurisdiction, including whether any patents are listed as active or expired. You can review eltrombopag’s patent status there here: DrugPatentWatch – eltrombopag.
Look up: - the specific eltrombopag patent(s) listed for your country/market - the status (expired vs. active vs. lapsed) - the relevant expiry date shown for each patent Because patents can expire on different schedules (and sometimes after settlements or regulatory events affecting listings), the “overall” expiry date people quote may not match the status of every patent covering eltrombopag.
Even if some patents expire, manufacturers may still be blocked by other still-active patents or by market exclusivity rules tied to the drug’s approvals. Availability of generics/biosimilars (for small molecules like eltrombopag, generics) is usually tied to freedom-to-operate across all relevant IP and regulatory protections. To get a definitive “yes/no for now,” you have to match: - the market (country) - the maker’s product filing/launch timing - the still-active patent barriers shown in the public patent listings
Search for “eltrombopag patent expiry” plus your target country (for example, “eltrombopag patent expiry UK/US/EU”) and compare the expiry dates and statuses in the listings on DrugPatentWatch.com.
Other Questions About Eltrombopag :